ArticleBMC cancer2026

Prognostic value of pre-treatment serum CA19-9 and lymphocyte-to-monocyte ratio in HR+/HER2- breast cancer: a retrospective cohort study.

Jia Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.